Navigation Links
Tailored Therapy May Help More Stop Smoking
Date:4/20/2010

People who metabolize nicotine slowly may need to wear nicotine patch longer, researchers say

TUESDAY, April 20 (HealthDay News) -- New research suggests that a set length of time for using the nicotine patch may not work for all smokers trying to kick the habit.

Researchers at the University of Pennsylvania School of Medicine have already discovered that some people -- about three-quarters of smokers -- break down (metabolize) nicotine more quickly from the patches than other people do. These people may do better by taking drugs like bupropion (Zyban).

And in the new study, researchers found that people who metabolized nicotine slowly did better if they used the nicotine patch for six months compared to slow metabolizers who were placed on the patch for only two months, followed by six months on a placebo (dummy) patch.

After six months there was no difference between the two groups.

While extended therapy helps people stay off tobacco and recover from lapses, "it only works as long as people are on it," noted Caryn Lerman, deputy director of the Abramson Cancer Center at the University of Pennsylvania, in a press release. "Those data lead to the compelling question of whether some smokers should be on nicotine patch therapy for the long term."

She said some patients may need to take treatment longer than the current recommended standard of two months.

The study is scheduled for release Tuesday at the American Association of Cancer Research's annual meeting in Washington D.C.

More information

The U.S. National Library of Medicine has more about quitting smoking.



-- Randy Dotinga



SOURCE: University of Pennsylvania School of Medicine, press release, April 20, 2010.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Targeted therapy prolongs life in patients with HER2-positive breast cancer
2. PharmMD Secures Investments to Fund New Opportunities in Medication Therapy Management
3. More smokers kick the habit with extended nicotine patch therapy, Penn research shows
4. Experts Issue Warning on Prostate Hormone Therapy
5. ASGCT: Gene Therapy Shows Promise for Patients with Pompe Disease
6. AAPM statement on quality radiation therapy
7. Congress Urged to Take Immediate Action to Ensure Frail Patients Continue to Receive Critical Therapy Services
8. Intensive Insulin Therapy Wont Boost Septic Shock Survival
9. News brief: Dermatologic infections in cancer patients treated with EGFRI therapy
10. A new target for lymphoma therapy
11. NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions ... definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... this summer’s edition of “Vision & Hearing,” advocating for active, healthy lifestyles and ... on resources available for individuals with hearing impairments and shares the latest innovations ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... handling handheld devices. Through an educational webinar, they will present the line of ... chance to learn how easy you can automate everyday pipetting tasks. , Ideal ...
(Date:8/18/2017)... ... August 18, 2017 , ... Hernandez Insurance Agencies, a northern ... the greater DC region, is inaugurating a “New Leash On Life” charity initiative ... training them to be companions for veterans in need. , The Semper K9 ...
(Date:8/18/2017)... ... 18, 2017 , ... Moore Insurance, a Houston area agency ... is launching a regional charity effort to provide publicity assistance and generate donations ... Tumor Foundation (PBTF) has raised nearly $30 million in donations that has been ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: